When to give FEIBA? An Essential Guide to Bypassing Agent Administration
•
4 min read
For individuals with hemophilia and inhibitors, the development of antibodies against standard clotting factors makes treatment challenging, necessitating the use of bypassing agents like FEIBA. Knowing **when to give FEIBA** is critical for effective bleeding management, whether for acute episodes or prophylactic care. This medication acts by circumventing the inhibited factor to restore the body's clotting ability.
